Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

Ondansetron: A selective 5HT3 receptor antagonist and it advances in drug delivery system

Breadcrumb

  • Home
  • Ondansetron: A selective 5HT3 receptor antagonist and it advances in drug delivery system

Supriya Subhas Jana, Mrunmayi Deepak Lad, Suranya Subramanian and Dhanashree Prakash Sanap *

Bharati Vidyapeeth’s College of Pharmacy, Sector-8, C.B.D. Belapur, Navi Mumbai, Maharashtra – 400614, India.
 
Review Article
World Journal of Advanced Research and Reviews, 2022, 16(03), 068-077
Article DOI: 10.30574/wjarr.2022.16.3.1275
DOI url: https://doi.org/10.30574/wjarr.2022.16.3.1275
 
Received on 15 October 2022; revised on 29 November 2022; accepted on 01 December 2022
 
Ondansetron is a serotonin (5HT3) receptor antagonist used for the prevention and treatment of postoperative nausea and vomiting. It is available in many dosage forms in the market. Various analytical methods used for the determination of Ondansetron have been studied in this review article such as UV spectroscopy, mass spectroscopy, high-performance liquid chromatography, high-performance thin layer chromatography, a new electrospray ionization mass spectrometry etc. Ondansetron in human plasma can be estimated using this method. With time many advances have been made in the formulation aspects of Ondansetron, such as now a days it is available in floating drug delivery, transdermal as well as gastroretentive and orodispersible drug delivery system. New novel technologies are also mentioned in this review article related to 3D printing, nanofibers etc
 
Ondansetron hydrochloride; Gastro retentive floating tablet; Validation; Spectrophotometric; 3D printing
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2022-1275.pdf

Preview Article PDF

Supriya Subhas Jana, Mrunmayi Deepak Lad, Suranya Subramanian and Dhanashree Prakash Sanap. Ondansetron: A selective 5HT3 receptor antagonist and it advances in drug delivery system. World Journal of Advanced Research and Reviews, 2022, 16(3), 068-077. Article DOI: https://doi.org/10.30574/wjarr.2022.16.3.1275

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution